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Isotonic quadriceps endurance 
is better associated with daily 
physical activity than quadriceps 
strength and power in COPD: 
an international multicentre 
cross‑sectional trial
Erik Frykholm1,7*, Sarah Gephine2,3,7, Didier Saey2, Arthur Lemson4, Peter Klijn5,6, 
Eline bij de Vaate5,François Maltais2, Hieronymus van Hees4 &André Nyberg1
Knowledge about modifiable determinants of daily physical activity (PA) in patients with chronic 
obstructive pulmonary disease (COPD) is crucial to design effective PA interventions. The present 
study aimed to determine the contribution of quadriceps strength, power and endurance to daily 
PA in COPD. Additionally, for quadriceps endurance, we also aimed to determine to what extent the 
association varies according to the mode of movement (isotonic, isometric, or isokinetic). Using a 
multicentre cross‑sectional trial design we determined the contribution of quadriceps function to 
daily PA (steps, sedentary time and time spent doing moderate‑to‑very‑vigorous physical activity 
[MVPA]) using bivariate and partial Pearson correlation analysis (r) and multiple linear regression 
models (ΔR2). Pre‑determined controlling factors were sex, age, body mass index (BMI), COPD‑
assessment test, forced expiratory volume in one second in percent of the predicted value  (FEV1pred), 
and distance walked on the 6‑minute walk test. Eighty‑one patients with COPD (mean ± SD: age 
67 ± 8 years,  FEV1pred 57 ± 19%, daily steps 4968 ± 3319, daily sedentary time 1016 ± 305 min, and MVPA 
time 83 ± 45 min) were included. Small to moderate bivariate correlations (r = .225 to .452, p < .05) were 
found between quadriceps function and measures of PA. The best multiple linear regression models 
explained 38–49% of the variance in the data. Isotonic endurance was the only muscle contributor that 
improved all PA models; daily steps (ΔR2 = .04 [relative improvement 13%] p = .026), daily sedentary 
time (ΔR2 = .07 [23%], p = .005) and MVPA‑minutes (ΔR2 = .08 [20%], p = .001). Isotonic endurance was 
also independently associated with most PA variables, even when controlling for strength, power or 
isometric‑isokinetic endurance properties of the muscle (r = .246 to .384, p < .05). In contrast, neither 
strength, power, isometric‑or isokinetic endurance properties of the muscle was independently 
associated with PA measures when controlling for isotonic endurance (r = .037 to .219, p > .05). To 
conclude, strength, power, and endurance properties of the quadriceps were low to moderately 
associated with PA in patients with COPD. Isotonic quadriceps endurance was the only quadriceps 
property that was independently associated with the different measures of PA after controlling for 
a basic set of known determinants of PA, quadriceps strength or power, or isometric or isokinetic 
quadriceps endurance. Future longitudinal studies should investigate its potential as a modifiable 
determinant of PA.
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Physical activity (PA) is recognized as an essential feature in patients with chronic obstructive pulmonary dis-
ease (COPD)1, being amongst the strongest predictors of all-cause mortality and quality of life in the  disease2–5. 
Importantly, PA levels can potentially be  improved1, and over recent years, several modifiable determinants of 
PA in COPD have been  identified3. Even so, there is still limited and inconsistent evidence on the effectiveness 
of interventions to enhance PA in  COPD1. Considering that knowledge about determinants of PA in patients 
with COPD is crucial to design effective PA  interventions3,6, these findings highlighting that other modifiable 
determinants of PA likely exists, even though they have yet to be  identified1,3.
Quadriceps dysfunction, defined by reduced strength, power or endurance properties of the quadriceps is a 
common extrapulmonary manifestation of the disease, evident in over a third of the COPD-population7,8. Even 
though improving quadriceps function often is an integrated aim of exercise  interventions1,7,9–11, information 
on the potential role of quadriceps function as a determinant of PA in COPD is sparse.
Other than quadriceps strength, shown not to be linked to PA in several different  studies12–14, there is today 
limited knowledge on the impact of other potentially modifiable properties of the quadriceps on PA in COPD. 
Recently, quadriceps power has emerged as a more important predictor of PA than quadriceps strength, being 
positively associated with active time per day as well as light intensity PA in  COPD13. However, to our knowledge, 
the role of quadriceps power to PA has only been investigated in this single study in which the sample size was 
small, and the study included only older men, highlighting a need for further  investigation13.
Another potentially modifiable determinant of PA is quadriceps endurance. The endurance capacity of the 
quadriceps may be of particular interest to PA, considering that the muscle’s ability to repeat a specific task over 
 time15 indicates a similarity in PA task requirements based on the repetitive nature of quadriceps use in everyday 
daily activities such as walking. For example, quadriceps endurance has previously been found to be indepen-
dently associated with walking distance on the 6-minute walk test (6MWT) even after controlling for quadri-
ceps  strength16. Considering the existing link between 6MWT and PA in  COPD3,17, these findings indicate that 
quadriceps endurance could also be more closely associated with PA than other aspects of quadriceps function.
The primary aim of the present study was, therefore, to determine and to compare the contribution of quadri-
ceps strength, power and endurance to PA in patients with COPD. Furthermore, in recent studies, static (iso-
metric) and dynamic (isotonic, isokinetic) endurance protocols have been found to reflect different aspects of 
quadriceps function in  COPD16,18. Thus, a secondary objective was to determine to what extent the association 
varies according to the mode of movement (isotonic, isometric, isokinetic). Amongst the quadriceps muscle 
properties examined, the main hypothesis was that quadriceps muscle endurance would show the strongest 
association and contribution to the physical activity measures.
Method
Study design and participants. The present study was a multicentre cross-sectional study conducted in 
Sweden, Canada, and the Netherlands. Participants in this prospective study were continuously enrolled with 
convince sampling at each centre. Participants were included in every month of the year, thereby covering all 
seasons. Inclusion criteria were at least 40 years of age, and a confirmed diagnosis of mild to very severe COPD 
according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD)  criteria19 controlled through 
medical records. Exclusion criteria’s consisted of recent COPD exacerbation (within  3 months), muscular-, 
rheumatic-, or cardiac disorders affecting testing procedures, and a daily dose of prednisone >10mg within 3 
months, also controlled through medical records, and self-reported regular quadriceps strengthening exercises.
Procedure. All participants attended two visits, and PA was measured for seven days, from 2016 to 2019. On 
the first visit were anthropometrics including body mass index (BMI), and symptoms on the COPD assessment 
test (CAT) collected. After that were a  6MWT20,  spirometry21, and an isometric quadriceps strength test per-
formed. The second visit included the assessment of isokinetic quadriceps power as well as isometric, isokinetic 
and isotonic quadriceps  endurance22 (Fig. 1).
Quadriceps function. Quadriceps strength, power and endurance were measured with a computerized 
dynamometer (Biodex System Pro 3 or 4 Biodex Medical Systems, Shirley, New York, NY, USA) using test pro-
cedures that have been described in detail  elsewhere22. Quadriceps strength was measured during a maximal 
voluntary contraction (MVC) using an isometric (static) protocol at a 90° knee  angle22, performed in line with 
international recommendations and reported in Newton-meters (Nm)7. Quadriceps power, equivalent to energy 
output per unit of time, was obtained from the average power developed during 30 maximal isokinetic contrac-
tions; results were expressed in  watt23,24.
Quadriceps endurance was assessed with three reliable  protocols22, all performed with similar (1) starting 
position (sitting, 90° knee angle, straps over the thigh and pelvis), (2) direction of movement (restricted by the 
lever arm), and (3) duration of the test (~ 60 s). The three protocols differed regarding the mode of contraction/
movement (isometric [static], isokinetic [dynamic, fixed speed], or isotonic [dynamic, fixed external loading]). 
The two dynamic protocols had identical range-of-motion (90° knee flexion to full individual knee extension 
− 5°), while the static protocol was performed at a 90° knee  angle22. Standardized verbal encouragements were 
given in all tests.
The isometric protocol consisted of a static contraction at 60% of MVC at 90° knee angle using visual feed-
back (results: total work (load [Nm] × seconds until momentary failure)22. The isokinetic endurance protocol 
consisted of 30 maximal dynamic contractions at a fixed pace of 90°/s (results: total work in Joule [J])22. The 
isotonic endurance test protocol consisted of the maximal amount of dynamic leg extensions throughout the full 
range of motion, performed using a resistance of 30% of isometric MVC maintaining an externally set pace by a 
metronome at 60 beats per minute (i.e., 30 repetitions/minute) (results: total work (load [Nm] × repetitions)22.
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PA. A tri-axial accelerometer (DynaPort MoveMonitor, McRoberts; Hague, the Netherlands) was used to 
measure PA. The accelerometer is considered valid for patients with  COPD25 and is a small, light ambulant 
measurement device (106.6 x 58 x 11.5 mm, 55 g) worn with an elastic belt on the lower back. Since the sen-
sors measure gravity (g) in static situations, the acceleration signal is expressed relative to g. The participants 
were instructed to wear the accelerometer for seven consecutive days, including a weekend day. The minimum 
wearing criteria was ≥ 4 days, with ≥ 8 h wearing time each  day26,27. Daily steps, daily sedentary time in minutes, 
and daily time spent in moderate to very vigorous activity (MVPA) were selected as these are the three most 
commonly used measures of PA in COPD intervention  studies1 and were considered to display different aspects 
of PA. PA measures were summarized for valid days by the manufacturer software. Thresholds for describing 
time spent at different intensity levels were; sedentary time < 1.5 metabolic equivalents (METs), and time spent 
in moderate to very vigorous activity ≥ 3 METs, as proposed by the American College of Sports  Medicine28. To 
define each individual’s average value during the physical activity measurement was the median from valid days 
used in the main analysis. To compare levels of PA between week- and weekend days, the individual’s median 
value during the valid week and weekend days was used.
Statistical analysis. A statistical software package was used for all calculations (Jamovi, version 1.6.7, Syd-
ney, Australia), a p value of < .05 was considered to indicate statistical significance. Contribution of quadriceps 
function to PA (daily steps, daily sedentary time, and daily MVPA-minutes) was determined through Pearson’s 
bivariate and partial correlations, and multiple linear regression analyses. Levels of PA between week- and week-
end was compared using paired t-tests and Pearson’s bivariate correlations. For bivariate analysis were correla-
tion coefficients (r) values in the range of < .1 considered trivial, .1–.3 small, .3–.5 moderate, .5–.7 large, .7–.9 
very large, and > .9 extremely  large29. Partial correlations analyses were used to examine the correlation between 
PA and one quadriceps property while controlling for another quadriceps property (e.g., the correlation between 
MVPA-minutes and quadriceps endurance while controlling for quadriceps strength). In the multiple linear 
regression analysis, daily steps, daily sedentary time, and daily MVPA-minutes represented dependant variables. 
Based on previous  literature3,13 and basic clinical  characteristics7 were sex, age in years, BMI, CAT score,  FEV1pred 
and 6MWT in meters selected as pre-determined independent variables and constituted the basic  model30,31. A 
minimum of 75 participants was aimed to be included based on the general rule that 10 to 15 subjects per predic-
tor are needed for a reliable  equation32. To determine the contribution of various quadriceps properties to PA in 
COPD, isometric strength, isokinetic power, as well as isotonic, isometric and isokinetic quadriceps endurance 
measurements were entered independently to the basic model. The models were then again applied to the three 
dependent PA variables. Outcomes to evaluate the contribution to PA included the standardized estimated effect 
of included variables, the predicting ability of the model using  R2, and absolute change (ΔR2) between the first 
and second models. Multicollinearity was evaluated with the tolerance and variance inflation factor (VIF) sta-
tistics with tolerance value > .1 and VIF < 10. The quality of the linear regression models was assessed using the 
Akaike information criterion (AIC) (lower score, better model)33.
Ethics approval and consent to participate. The study was conducted in accordance with the declara-
tion of Helsinki and was approved by the respective local ethical boards (regional medical ethics committee of 
Umeå: DNR: 2015-426-31M, 2016-379-32M; Comité éthique du Centre de Recherche, Institut Universitaire de 
Cardiologie et de Pneumologie de Québec, Université Laval: CER: 21322; Committee on Research Involving 
Human Subjects (CMO) region Arnhem-Nijmegen: CMO: NL59926.091.16), all participants received written 
and verbal information about the study and gave their written informed consent before the study commenced.
Results
Eighty-one participants with COPD were included in the analysis, 4 participants were excluded from the analysis, 
either missing a valid isometric quadriceps muscle endurance measurement (n = 3) or isotonic quadriceps muscle 
endurance measurement (n = 1). The PA measurement covered both weekdays and weekends for all participants. 
Eighty participants had at least one valid weekend day. Table 1 display participant characteristics, PA measures, 
Figure 1.  Description of study procedure. CAT COPD assessment test, MRC Medical Research Council 
dyspnea scale, 6MWT 6-minute walking test, MVPA time spent in moderate to very vigorous intensity. 
*Randomized order, POWER, was obtained from the isokinetic protocol.
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and quadriceps functions, Table 2 displays bivariate and partial correlation coefficients, Table 3 displays the  R2, 
and ΔR2 of each multiple linear regression model, while Table 4 displays the standardized estimated effect of 
the models with the best coefficient of determination for daily steps, sedentary time, and MVPA-minutes. No 
multicollinearity was observed in the multiple analyses.
Pearson’s correlation and multiple linear regression analyses. Small to moderate significant cor-
relations (r = .219 to .452) were found between different quadriceps function properties and all PA measures. 
Partial correlation analyses on strength, power and endurance properties of the quadriceps revealed that iso-
tonic quadriceps endurance was independently associated with all PA measures after controlling for quadri-
ceps strength as well as independently associated with sedentary time and MVPA-minutes but not daily steps 
(r = .201, p = .07) when controlling for quadriceps power. In contrast, neither strength nor quadriceps power was 
independently associated with PA measures when controlling for isotonic endurance. Similarly, other than daily 
steps when controlling for isokinetic endurance (r = .200, p = .08), isotonic quadriceps endurance was also inde-
pendently associated with PA measures when controlling for isometric and isokinetic endurance. At the same 
time, no significant associations were seen between PA measures and isometric and isokinetic endurance when 
controlling for isotonic endurance (Table 2).
The basic multiple linear regression model, including the pre-determined variables sex, age in years, BMI, 
CAT score,  FEV1pred and distance walked on the 6MWT explained 31–41% of the variance in the PA data  (R2: 
daily steps .37, daily sedentary time .31 and MVPA-minutes .41). Isotonic quadriceps endurance was included 
in the best model to additionally explain variability of daily steps (ΔR2 = .04 [relative improvement of the 
model = 13%] p = .026), daily sedentary time (ΔR2 = .07 [23%], p = .005) and MVPA-minutes (ΔR2 = .08 [20%], 
p = .001), resulting in 38–49% of the variance in PA being explained (Tables 3 and 4). Quadriceps strength or 
Table 1.  Participant characteristics. Values are means ± standard deviations or number and (%). Activity 
measures are means of individual daily medians of minutes or steps, of at least four days of measurements 
and at least eight hours of wearing time. Thresholds for describing time spent at different intensity levels are 
proposed by the American College of Sports Medicine: Sedentary time < 1.5METs, time spent in moderate to 
very vigorous activty ≥ 3 to > 9 METs. FEV1 forced expiratory volume in the first second, FEV1pred FEV1 in 
percent of predicted, FVC forced vital capacity, FVCpred FVC in percent of predicted, GOLD Global Initiative 
for Lung Disease, MRC Medical Research Council dyspnea scale, CAT COPD assessment test higher values 
indicating more symptoms, BMI body mass index, 6MWT 6-minute walk test, MVC maximal isometric 
voluntary contraction, METs metabolic equivalents.
Characteristic n = 81
Age, years 67 ± 8
Sex, females/males 35/46 (43/57)
FEV1, L 1.5 ± .6
FEV1pred, % 57 ± 19
FVC, L 3.3 ± .9
FVCpred, % 98 ± 21
FEV1/FVC, % 46 ± 13
GOLD grade, n I/2/3/4 (%) 12/37/23/9 (15/46/28/11)
MRC, n 1/2/3/4/5 (%) 1/35/15/8/22 (1/43/19/10/27)
CAT, 0–40 16 ± 7
BMI, kg/m2 27 ± 5
6MWT, m 452 ± 123
6MWT % predicted 78 ± 23
Physical activity
Wearing time, % 83 ± 20
Valid days, n 7 ± 1
Steps, n 4968 ± 3319
Sedentary time, minutes 1016 ± 305
Moderate to very vigorous activity, minutes 83 ± 45
Quadriceps function
STRENGTH, MVC, Nm 132 ± 47
STRENGTH, MVC % predicted 73 ± 18
POWER, Watt 59 ± 23
ENDURANCE, isotonic, Nm × repetitions 1274 ± 1065
ENDURANCE, isometric, Nm × seconds 3842 ± 2325
ENDURANCE, isokinetic, Joule 2001 ± 862
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Table 2.  Pearson bivariate and partial correlation (r) analysis coefficients between quadriceps functions 
and daily physical activity measures . MVC maximal isometric voluntary contraction, MVPA time spent in 
moderate to very vigorous intensity. *p < .05, **p < .01, ***p < .001.
Steps per day Sedentary time MVPA-minutes
Quadriceps function
STRENGTH, MVC 0.264* − 0.259* 0.353**
 + controlling for POWER 0.060 − 0.124 0.095
 + controlling for ENDURANCE, isotonic 0.037 − 0.062 0.066
 + controlling for ENDURANCE, isometric 0.068 − 0.163 0.148
 + controlling for ENDURANCE, isokinetic 0.067 − 0.118 0.115
POWER, Watt 0.313** − 0.347** 0.409***
 + controlling for MVC 0.184 − 0.239* 0.239*
 + controlling for ENDURANCE, isotonic 0.128 − 0.101 0.177
 + controlling for ENDURANCE, isometric 0.132 − 0.273 0.223*
 + controlling for ENDURANCE, isokinetic 0.047 − 0.338** 0.098
ENDURANCE, isotonic, Nm × Reps 0.346** − 0.435*** 0.452***
 + controlling for MVC 0.246* − 0.366*** 0.307**
 + controlling for POWER 0.201 − 0.279* 0.272*
 + controlling for ENDURANCE, isometric 0.174 − 0.384*** 0.279*
 + controlling for ENDURANCE, isokinetic 0.200 − 0.365*** 0.280*
ENDURANCE, isometric, Nm × seconds 0.367*** − 0.225* 0.422***
 + controlling for MVC 0.273* − 0.096 0.268*
 + controlling for POWER 0.241* − 0.258* 0.249*
 + controlling for ENDURANCE, isotonic 0.217 − 0.040 0.219
 + controlling for ENDURANCE, isokinetic 0.242* − 0.100 0.258*
ENDURANCE, isokinetic, Nm 0.315** − 0.256* 0.402***
 + controlling for MVC 0.191 − 0.110 0.233*
 + controlling for POWER 0.061 − 0.003 0.047
 + controlling for ENDURANCE, isotonic 0.134 − 0.025 0.169
 + controlling for ENDURANCE, isometric 0.140 − 0.160 0.217
Table 3.  Multiple linear regression analyses. The basic model includes; sex, age in years, body mass index, 
COPD Assessment Test score, forced expiratory volume in the first secondin % of predicted, and 6-minute 
walk test distance. ΔR2 change in  R2 from the basic model. AIC Akaike information criterion, MVC maximal 
isometric voluntary contraction, MVPA time spent in moderate to very vigorous intensity. *p < .05, **p < .01, 
***p < .001.
Model R2 ΔR2 p AIC
Steps per day
Basic model .373 1520
 + STRENGTH, MVC 0.376 <0 .01 0.559 1522
 + POWER, Watt 0.381 0.01 0.356 1521
 + ENDURANCE, isotonic 0.415 0.04 0.026* 1517
 + ENDURANCE, isometric 0.400 0.03 0.053 1518
 + ENDURANCE, isokinetic 0.387 0.01 0.214 1521
Sedentary time
Basic model 0.309 1805
 + STRENGTH, MVC 0.310 < 0.01 0.722 1807
 + POWER, Watt 0.332 0.02 0.114 1804
 + ENDURANCE, isotonic 0.379 0.07 0.005** 1798
 + ENDURANCE, isometric 0.316 < 0.01 0.367 1806
 + ENDURANCE, isokinetic 0.312 < 0.01 0.551 1807
MVPA-minutes
Basic model 0.407 1482
 + STRENGTH, MVC 0.422 0.01 0.184 1482
 + POWER, Watt 0.432 0.02 0.082 1480
 + ENDURANCE, isotonic 0.489 0.08 0.001** 1472
 + ENDURANCE, isometric 0.446 0.06 0.006* 1476
 + ENDURANCE, isokinetic 0.439 0.03 0.048* 1480
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power did not improve any model while isometric endurance improved  the MVPA model (ΔR2 = .06 [10%], 
p = .006). The MVPA model also improved by isokinetic endurance (ΔR2 = .03 [8%], p = .048) (Table 3).
Group means of the individual’s average value using medians for valid week- and weekend days separately 
show higher daily steps and daily MVPA-minutes during weekdays than during weekends (mean ± standard 
deviation: weekday daily steps 5162 ± 3498 vs. weekend daily steps 4685 ± 3203, p = .029, weekday MVPA-minutes 
86.6 ± 48.5 vs. weekend MVPA-minutes 80.8 ± 45.0, p = .040), sedentary time was not different (weekday sedentary 
minutes 1014 ± 300 vs. weekend sedentary minutes 1015 ± 302, p = .993). The correlations between weekday and 
weekend PA were very large (r = .84–.87, p < .001).
Discussion
The main findings of the present study are that strength, power and endurance properties of the quadriceps 
are significantly associated with PA in patients with COPD. Of the included measures of quadriceps function, 
quadriceps endurance was the only muscle property that was associated with daily steps, daily sedentary time 
and MVPA-minutes even after controlling for a basic set of known determinants of PA or when controlling for 
strength-power properties of the muscle. Our result also indicate that the mode of movement is of importance 
as isotonic quadriceps endurance was independently associated with PA in COPD even when controlling for 
isometric or isokinetic quadriceps endurance. In contrast, neither strength, power nor isometric and isokinetic 
endurance properties were independently associated with PA measures, when controlling for isotonic endurance.
Interpretation of study results. Quadriceps strength was associated with all PA measures, however, when 
added to a basic set of known determinants of PA (sex, age, BMI,  FEV1pred, CAT, 6MWT) quadriceps strength 
was not a significant contributor to any of the models. These findings are in line with previous  research12,13,34. 
However, considering the known link between BMI and quadriceps strength in  COPD35, it should be noted 
that the lack of added predictive value of quadriceps strength to the basic set of variables, may, at least partly, 
be explained by that BMI was one of the basic variables. Furthermore, quadriceps power was recently found 
to be positively associated with light intensity PA, and active time per day (r = .37 to .51), but not daily steps in 
older men with COPD (r = .30, p > .05)13. In the present study, active time per day and light intensity PA was 
not explicitly investigated but isokinetic quadriceps power was associated with all included aspects of PA, even 
daily steps (r = .313, p < .01). About the latter, considering the similarity in the coefficient of correlation in the 
present study (r = .313) and in the study of Hernandez et al. (r = .300), the lack of statistical significance in the 
latter study was likely due to the lower sample size (n = 44 vs. n = 81)13. Nevertheless, even though quadriceps 
power has been highlighted as a more important predictor of PA than maximum  strength13, the results from the 
present study indicate that it does not seem to add additional value when added to already known determinants 
of PA in COPD, or when compared to the endurance capacity of the quadriceps. It should be noted that the 
recognised link between isokinetic power and distance walked on the  6MWT18 likely contributed to why the 
basic models were not further improved by isokinetic power. However, in contrast, the endurance capacity of the 
quadriceps improved PA models when added to the basic models despite the known link to distance walked on 
the  6MWT16,36. Our observed findings are further supported by the results from the partial correlation analysis 
in which neither quadriceps strength nor power was independently associated with PA when controlling for 
isotonic quadriceps endurance. In contrast, isotonic quadriceps endurance was, except for steps per day when 
controlling for quadriceps power, independently associated with daily steps, sedentary time and MVPA-minutes 
even after controlling for strength and power properties of the quadriceps. Similarly, isotonic quadriceps endur-
Table 4.  Standardized estimates of the multiple linear regression models with the best coefficient of 
determination for sedentary time, daily steps, and MVPA-minutes. Models with a measure of quadriceps 
endurance are shown when there was a significant change in the coefficient of determination from the basic 
model including; gender, age in years, BMI, CAT, FEV1pred and 6MWT. MVPA time spent in moderate to 
very vigorous intensity, BMI body mass index, CAT COPD assessment test, higher values indicating more 
symptoms, FEV1pred forced expiratory volume in the first second in percent of predicted, 6MWT 6-minute 
walk test. *p < .05, **p < .01, ***p < .001, †the best quadriceps function from the multiple linear regression 
analyses.







Lower Upper Lower Upper Lower Upper
Basic model
Sex 0.94 0.01 − 0.19 0.21 0.21 0.13 − 0.08 0.34 0.68 0.04 − 0.15 0.23
Age 0.42 − 0.08 − 0.28 0.12 0.60 0.05 − 0.15 0.26 0.17 − 0.13 − 0.31 0.06
BMI 0.08 − 0.18 − 0.38 0.02 0.95 0.01 − 0.20 0.23 0.01* − 0.25 − 0.44 − 0.06
CAT 0.29 0.11 − 0.10 0.31 0.12 0.17 − 0.05 0.38 0.61 − 0.07 − 0.25 0.10
FEV1pred 0.02* 0.27 0.05 0.49 0.33 − 0.11 − 0.11 0.33 0.07 0.19 − 0.03 0.30
6MWT < 0.01** 0.35 0.11 0.60 < 0.01** − 0.37 − 0.63 − 0.12 < 0.01** 0.32 0.09 0.55
 + ENDURANCE, 
isotonic† 0.03* 0.25 0.03 0.48 < 0.01** − 0.33 − 0.56 − 0.10 < 0.01** 0.36 0.15 0.56
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ance was independently associated with most PA measures even after controlling for isometric or isokinetic 
quadriceps endurance measurements.
Clinical relevance. As previously reported,  FEV1pred, BMI, and distance walked on the 6MWT were signifi-
cant contributors to the best models to determine PA. In fact, the distance walked on the 6MWT is consistently 
found associated with measures of PA in COPD, and often considered one of the best available determinants of 
PA in  COPD3. The findings from the present study demonstrate that strength, power and endurance properties 
of the quadriceps are also low to moderately associated with PA in patients with COPD. Isotonic quadriceps 
endurance was  the only significant muscle contributor to all PA models, resulting in an absolute improvement of 
the basic models with 4 to 8% (relative improvement 13 to 23%). Isotonic quadriceps endurance was also inde-
pendently associated with PA in COPD even after controlling for strength/power or other modes (isometric/
isokinetic). In contrast, neither strength/power nor other modes of quadriceps endurance was associated with 
any of the included PA measures when controlling for isotonic endurance. A possible explanation for these find-
ings is that isotonic endurance measurements, in a similar way as many daily physical activities, e.g., going for a 
brief daily walk, consists of dynamic submaximal movements/contractions. In contrast, isometric measurements 
are static (i.e., no movement) while isokinetic power and endurance measurements consist of maximal, and not 
submaximal  contractions8,22–24.
The relevance of the association of isotonic quadriceps endurance when estimating PA can be extrapolated 
to a clinical example. Based on the predictive models, an improvement of roughly 37% in isotonic quadriceps 
endurance would be needed to achieve a clinically relevant 600-daily step improvement in  PA37, if all other factors 
remain constant. For the 6MWT, the corresponding change for a similar improvement in isotonic quadriceps 
endurance based on our data would be 63 m. Even though these estimations should be interpreted cautiously 
due to the cross-sectional nature of the data which prevent concluding on cause and effect, other research groups 
have found that trials with significant improvement in PA have also demonstrated considerable improvements 
in distance walked on the 6MWT (47 to 79 m)38–40. One of the studies also reports improvements of isometric 
quadriceps endurance of ~ 35% and isometric quadriceps strength of ~ 14% after an intervention with high-
intensity interval training on stationary bicycles with significant improvements in several PA  measures40. To our 
knowledge, isotonic quadriceps endurance has not been evaluated in trials that have demonstrated significant 
improvements in PA. Still, isotonic quadriceps endurance is repeatedly shown to be highly adaptable (+ 50 to 
97%) by exercise  interventions11,41,42.
Taken together with the observation that isotonic endurance also was independently associated with most 
PA measures even when controlling for strength, power, or isometric- and isokinetic endurance properties of the 
quadriceps, our results indicate that isotonic quadriceps endurance seems to be more closely associated with PA 
than other aspects of quadriceps function. Nevertheless, and as further described in the strengths and limitations 
of the study, only about half or less of the variation in PA is explained in our models, despite including a wide 
range of known determinants of PA among patients with COPD, and bivariate and partial correlations mainly 
demonstrated low to moderate associations for quadriceps muscle properties and PA in COPD.
Strengths and limitations
The international multicentre design with continuous data collection, the broad spectrum of disease severity and 
the direct comparison of several different aspects of quadriceps function are key strengths of the current study, 
increasing generalizability and facilitating the interpretation of the role of quadriceps function to PA in COPD. 
However, in line with the findings from the present study, it should be noted that strength, power and endur-
ance properties of the quadriceps could be measured in various  ways8,43–45. Thus, we cannot be certain that the 
results would have been similar if other strategies were also used. Nevertheless, isometric MVC was chosen as a 
measure of quadriceps strength since it, to date, is the recommended approach to assess quadriceps strength in 
 COPD7. For quadriceps power, no such specific assessment recommendation  exist44. However, other strategies 
such as the stair climb power  test46, sit to  stand47 or isotonic measures of  power24 exist and may have provided 
other information, even though this needs to be further investigated. Furthermore, even though several different 
PA measures  exist1,3, daily steps, sedentary time and MVPA-minutes were selected as these are the three most 
commonly used outcomes of PA in intervention studies targeting PA in  COPD1. Steps and MVPA-minutes were 
lower during the weekend than during weekdays (− 476 steps/day and − 5.8 MVPA-minutes), but with very large 
correlations, as shown previously in  COPD48. Inclusion of both week and weekend days resulted in more valid 
days in the main analysis, and the associations, therefore, reflect an average of valid days and not any specific part 
of the week. Lastly, an important notion is that only about half or less of the variation in PA is explained in our 
models, despite including known determinants of PA among patients with  COPD3. The explanatory degree in the 
present study may have been further improved by the inclusion of more known factors than those  selected3,49,50.
Firstly, have limitations in chest wall volume measurements, and central hemodynamic and peripheral muscle 
oxygenation been investigated and show that quadriceps muscle oxygen saturation and inspiratory reserve chest 
wall volume as the significant best contributors, explaining 77.7% of the variance in daily movement  intensity49,50. 
However, movement intensity was not used as a dependent variable in this study, and movement intensity and 
movement amount (steps and time in activity) might reflect different aspects of  PA6,48.
Secondly, in combination with the notion that included participants, even though representative in all GOLD 
stages, had a relatively well-preserved functional exercise capacity (only 22% walked < 350 m on the 6MWT). 
Factors other than pure physiological factors, such as motivation, social participation, meaningful interpersonal 
interactions, readiness to change and self-efficacy may have provided additional value and should be consid-
ered in future  studies1,51. And thirdly, testing also other muscle groups, such as the calf-muscles, could also 
provide additional value considering the know link between the calf-muscles and walking ability in  COPD52. 
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Nevertheless, we do believe that this basic set of factors was sufficient for the present study’s aim, that is, to 
determine and compare the association between different aspects of quadriceps function and PA in COPD.
Conclusion
In conclusion, this study found that strength, power and endurance properties of the quadriceps were low to 
moderately associated with PA in patients with COPD, but that isotonic quadriceps endurance was the best, and 
the only quadriceps property that was associated with all the different measures of PA (daily steps, daily sedentary 
time and MVPA-minutes) even after controlling for a basic set of known determinants of PA or when control-
ling for strength or power properties of the muscle. Thus, altogether these findings highlight that the endurance 
capacity of the quadriceps seems to be a new potentially modifiable determinant of PA in COPD that may be con-
sidered if the goal is to optimize the role of exercise training as a mean to improve PA in COPD, even though this 
needs to be confirmed in future longitudinal studies. Furthermore, when examining quadriceps endurance, the 
mode of movement seems to be important as isotonic quadriceps endurance was independently associated with 
most PA measures even when controlling for isometric and isokinetic endurance properties of the quadriceps.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on 
reasonable request.
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